Research into the Value of B-Mode Ultrasound, CT and MRI Examinations in the Diagnosis of Preoperative Myometrial Infiltration of Endometrial Cancer and Lymph Node Metastasis

• Authors: Ren Lu , Sun Guixia
• Languages of publication: EN

Abstracts

EN

This study is conducted to observe the diagnostic value of B-mode ultrasound, CT and MRI examinations in preoperative myometrial infiltration of endometrial cancer and lymph node metastasis. Retrospectively analyze 50 cases of the patients from Oct. 2010 to Aug. 2013. Before operation all the patients received dilatation & curettage to determine pathological diagnosis and clinical staging. There were 150 cases of patients who received B-mode ultrasound examination, wherein, 93 cases received CT examination and 57 cases received MRI examination as well. In the diagnosis of MIEC the diagnostic indicies of individual MRI examination were higher than that of individual B-mode ultrasound and CT examinations. Consistency of individual MRI examination with pathological diagnosis was significantly higher than that of B-mode and CT examinations. The sensitivity of CT and MRI was significantly higher than that of B-mode ultrasound examination. However, diagnostic indicators of B-mode ultrasound and CT joint examination were higher than B-mode ultrasound examination alone. The consistency of both with pathological diagnosis was significantly increased. B-mode and CT can significantly improve the diagnostic accuracy and has a good consistency with pathological diagnosis, thereby applicable to the clinical diagnosis of preoperative myometrial infiltration of endometrial cancer and lymph node metastasis.

Keywords

EN

B-mode ultrasound; CT; MRI; endometrial cancer; myometrial infiltration; lymph node metastasis

• Publisher: De Gruyter Open
• Journal: Open Medicine
• Year: 2014
• Volume: 10
• Issue: 1

Dates

published

1 - 1 - 2015

online

17 - 12 - 2015

accepted

23 - 9 - 2015

received

29 - 6 - 2015

Contributors

author

Ren Lu

• Huaihe Hospital of Henan University, 475000, China, Tel.: [phone]

author

Sun Guixia

• Huaihe Hospital of Henan University, Henan, China

References

• [1] Stringer E.M., Fleming G.F., Hormone Therapy plus mTOR Inhibitors in the Treatment of Endometrial Carcinoma, J. Oncol Hematol Rev., 2013, 9(1), 41-44[Crossref]
• [2] Touboul C., Piel B., Koskas M., et al., Factors predictive of endometrial carcinoma in patients with atypical endometrial hyperplasia on preoperative histology, J. Anticancer Res., 2014, 34(10), 5671-5676
• [3] Sorbe B., Juresta C., Ahlin C., Natural history of recurrences in endometrial carcinoma, J. Oncol Lett., 2014, 8(4), 1800-1806[WoS]
• [4] Hosoi A., Ueda Y., Shindo M., et al., Endometrial thickness measured by ultrasonography in postmenopausal patients with endometrial carcinoma has significance, irrespective of histological subtype, J. Int J Gynecol Cancer, 2013, 23(7), 1266-1269[Crossref][WoS]
• [5] Wan Q., Jiao Q., Li X., et al., Value of (18)F-FDG PET/CT and MRI in diagnosing primary endometrial small cell carcinoma, J. Chin J Cancer Res., 2014, 26(5), 627-631[WoS]
• [6] Koplay M., Dogan N.U., Erdogan H., et al., Diagnostic efficacy of diffusion-weighted MRI for pre-operative assessment of myometrial and cervical invasion and pelvic lymph node metastasis in endometrial carcinoma, J. J Med Imaging Radiat Oncol., 2014, 58(5), 538-546[Crossref][WoS]
• [7] Baek M.H., Lee S.W., Park J.Y., et al., Feasibility and safety of laparoscopic surgery for obese korean women with endometrial cancer: long-term results at a single institution, J. Korean Med Sci., 2014, 29(11), 1536-1543[WoS][Crossref]
• [8] Yost K.J., Cheville A.L., Al-Hilli M.M., et al., Lymphedema after surgery for endometrial cancer: prevalence, risk factors, and quality of life, J. Obstet Gynecol., 2001, 124, 307-315[WoS]
• [9] Rajasooriyar C., Bernshaw D., Kondalsamy-Chennakesavan S., et al., The survival outcome and patterns of failure in node positive endometrial cancer patients treated with surgery and adjuvant radiotherapy with curative intent, J. Gynecol Oncol., 2014, 25(4), 313-319[Crossref]
• [10] Nagao S., Nishikawa T., Hanaoka T., et al., Feasibility Study of Combination Chemotherapy with Paclitaxel, Doxorubicin and Cisplatin without Prophylactic Granulocyte Colonystimulating Factor Injection for Intermediate-to-high Risk or Recurrent Endometrial Cancer, J. Jpn J Clin Oncol., 2014, 44(11), 1040-1044 [Crossref]

Identifiers

DOI

10.1515/med-2015-0068